Studie start i morgen på Zealand Pharma'dasiglucagon studie!
-
Ifølge Clinical Trial Gov så er der "Estimated Study Start Date: September 28, 2018" på studiet med titlen "A phase 3, randomized, double-blind, placebo- and active-controlled, parallel-arm trial to assess the efficacy, safety, and pharmacokinetics of dasiglucagon relative to placebo and GlucaGen
when administered as a rescue therapy for severe hypoglycemia in children with T1DM treated with insulin". -
Vi har spørgsmål til netop dette forsøg i vor seneste Q&A med Zealand Pharma.
-
Hej ElliotSpitzer, Har du et bud på tidshorisonten på studiet? På forhånd tak. Mvh Bent
-
Estimated Primary Completion Date : July 1, 2019
Estimated Study Completion Date : August 1, 2019 -
Nu kom der så også meddelse om det - Kl. 14:53:11 CET
Company announcement - No. 24 / 2018
Zealand Pharma has initiated the Phase 3 trial with dasiglucagon for treatment of severe hypoglycemia in children
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind